Publications by authors named "Rachel Silk"

Claim this Profile
S
Sustained Impact of Task-shifting HCV Treatment to Nonspecialist Providers: 5-Year Follow Up of the ASCEND Investigation.
Sarah Mollenkopf, Elana Rosenthal, Geb Teferi, Rachel Silk, Nivya George

Open Forum Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Sequential Mixed-Methods Study of Factors Associated with Low High-Resolution Anoscopy Completion in Transgender Women with Abnormal Anal Cytology.
Omar Harfouch, Darren Whitfield, Tural Mammadli, Rahwa Eyasu, Connor Volpi, Rachel Silk

AIDS Patient Care STDS· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Rates of High-risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at Birth.
Omar Harfouch, Andrea Lisco, Habib Omari, Rahwa Eyasu, Ashley Davis, Rachel Silk

Open Forum Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multimodal Ayurveda and Mind-Body Therapeutic Intervention for Chronic Symptoms Attributed to a Postinfectious Syndrome: A Pilot Study.
Kalpana D Shere-Wolfe, Nivya George, Gulam Muhammed Al Kibria, Rachel Silk, Carla S Alexander

J Integr Complement Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use.
Max Spaderna, Sarah Kattakuzhy, Sun Jung Kang, Nivya George, Phyllis Bijole, Rachel Silk

Int J Drug Policy· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV.
Kristi C Hill, Sarah M Kattakuzhy, Rachel Silk, Rahwa Eyasu, Onyinyechi Ogbumbadiugha

Open Forum Infect Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment.
Kristi Hill, Laura Nussdorf, Julia D Mount, Rachel Silk, Chloe Gross

J Addict Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment.
Christopher Brokus, Sarah Kattakuzhy, Britt Gayle, Shivakumar Narayanan, Ashley Davis, Rachel Silk

Open Forum Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.
Elana S Rosenthal, Rachel Silk, Poonam Mathur, Chloe Gross, Rahwa Eyasu

Clin Infect Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term changes in hepatic fibrosis following hepatitis C viral clearance in patients with and without HIV.
Julia B Balmaceda, Julia Aepfelbacher, Olivia Belliveau, Chloe S Chaudhury, Cheryl Chairez, Rachel Silk

Antivir Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance.
Chloe S Chaudhury, Thomas Mee, Cheryl Chairez, Mary McLaughlin, Rachel Silk

Clin Infect Dis· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Practical Approach and Model of Care for HCV Treatment With Direct Acting Antivirals in an Urban Setting.
Elizabeth Akoth, Chloe Gross, Rachel Silk, Elana Rosenthal, Sarah Kattakuzhy

J Assoc Nurses AIDS Care· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.
Chloe S Chaudhury, Julia Sheehan, Cheryl Chairez, Elizabeth Akoth, Chloe Gross, Rachel Silk

J Infect Dis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.
Sarah Kattakuzhy, Chloe Gross, Benjamin Emmanuel, Gebeyehu Teferi, Veronica Jenkins, Rachel Silk

Ann Intern Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV/HCV Co-infection: Overcoming Barriers to Treatment.
Chloe Gross, Elizabeth Akoth, Angie Price, Sarah Kattakuzhy, Rachel Silk

J Assoc Nurses AIDS Care· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study.
Tess Petersen, Kerry Townsend, Lori A Gordon, Sreetha Sidharthan, Rachel Silk

Hepatol Int· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.
Sarah Kattakuzhy, Eleanor Wilson, Sreetha Sidharthan, Zayani Sims, Mary McLaughlin, Rachel Silk

Clin Infect Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens.
Eleanor M Wilson, Sarah Kattakuzhy, Sreetha Sidharthan, Zayani Sims, Lydia Tang, Rachel Silk

Clin Infect Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial.
Anita Kohli, Sarah Kattakuzhy, Sreetha Sidharthan, Amy Nelson, Mary McLaughlin, Rachel Silk

Ann Intern Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study.
Anita Kohli, Rama Kapoor, Zayani Sims, Amy Nelson, Sreetha Sidharthan, Rachel Silk

Lancet Infect Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.
Anu Osinusi, Kerry Townsend, Anita Kohli, Amy Nelson, Cassie Seamon, Rachel Silk

JAMA· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study.
Anita Kohli, Anuoluwapo Osinusi, Zayani Sims, Amy Nelson, Eric G Meissner, Rachel Silk

Lancet· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study.
Anu Osinusi, Anita Kohli, Miriam M Marti, Amy Nelson, Xiaozhen Zhang, Rachel Silk

Ann Intern Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.
Anuoluwapo Osinusi, Eric G Meissner, Yu-Jin Lee, Dimitra Bon, Laura Heytens, Rachel Silk

JAMA· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis